Jane A. Gross

Insider Reports History

Location
Seattle, WA
Signature
/s/ Nancy E. Denyes, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane A. Gross:

Stock Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Director Common Stock 9.75K $39K $4.00 17 Mar 2025 Direct
aTYR PHARMA INC Director Stock Option (right to buy) 50K 01 May 2025 Direct

Insider Reports Filed by Jane A. Gross

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ATYR aTYR PHARMA INC 01 May 2025 1 $0 4 Director 02 May 2025, 17:20
ATYR aTYR PHARMA INC 17 Mar 2025 1 $15K 4 Director 17 Mar 2025, 19:07
LIFE aTYR PHARMA INC 22 May 2024 1 $0 4 Director 23 May 2024, 19:27
LIFE aTYR PHARMA INC 17 May 2023 1 $0 4 Director 19 May 2023, 16:29
LIFE aTYR PHARMA INC 26 Apr 2023 2 $0 4 Director 28 Apr 2023, 16:52
BCTX BriaCell Therapeutics Corp. 01 Aug 2022 0 $0 3 Director 01 Aug 2022, 16:10
LIFE aTYR PHARMA INC 26 Apr 2022 1 $0 4 Director 28 Apr 2022, 19:46